Drug intelligence / Profile preview

testosterone undecanoate + dutasteride

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

Testosterone undecanoate + dutasteride is a combination therapy consisting of an androgen (testosterone undecanoate) and a dual 5α-reductase inhibitor (dutasteride). Testosterone undecanoate is an ester prodrug of testosterone used for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism. It restores physiological levels of testosterone to treat symptoms related to deficiency such as reduced libido and muscle mass[4][5][7]. Dutasteride inhibits both type I and II 5α-reductase enzymes that convert testosterone into dihydrotestosterone (DHT), thereby reducing DHT-mediated effects like prostate enlargement[1]. The combination may be used experimentally or off-label to optimize androgen replacement while minimizing DHT-related side effects such as acne or benign prostatic hyperplasia. Dutasteride can also increase the oral bioavailability of testosterone by suppressing its conversion to DHT[3][5].

Brand names
KyzatrexTlandoUndecatrexAndriol
Other names
testosterone undecanoate + dutasterideTU + dutasteride
02

Targets

SRD5A1 (Steroid 5-alpha-reductase type 1)SRD5A2 (Steroid 5-alpha-reductase type II)AR (Adrenergic receptors)

Beyond the preview

Go deeper on testosterone undecanoate + dutasteride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on testosterone undecanoate + dutasteride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call